BML Investment Partners, L.P. 13D/13G Filings for PMV Pharmaceuticals, Inc. (PMVP)

BML Investment Partners, L.P. 13D and 13G filings for PMV Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-12-12
12:29 pm
Purchase
2024-12-0613GPMV Pharmaceuticals, Inc.
PMVP
BML Investment Partners, L.P.3,269,907
6.300%
3,269,907increase
(New Position)
Filing